- Home
- ALDX vs PSF Comparison
ALDX vs PSF Comparison
Compare ALDX & PSF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALDX
- PSF
- Stock Information
- Founded
- ALDX 2004
- PSF 2010
- Country
- ALDX United States
- PSF United States
- Employees
- ALDX N/A
- PSF N/A
- Industry
- ALDX Biotechnology: Pharmaceutical Preparations
- PSF Investment Managers
- Sector
- ALDX Health Care
- PSF Finance
- Exchange
- ALDX Nasdaq
- PSF Nasdaq
- Market Cap
- ALDX 343.5M
- PSF 256.1M
- IPO Year
- ALDX 2014
- PSF N/A
- Fundamental
- Price
- ALDX $5.55
- PSF $20.61
- Analyst Decision
- ALDX Strong Buy
- PSF
- Analyst Count
- ALDX 4
- PSF 0
- Target Price
- ALDX $9.33
- PSF N/A
- AVG Volume (30 Days)
- ALDX 452.1K
- PSF 25.0K
- Earning Date
- ALDX 11-01-2024
- PSF 01-01-0001
- Dividend Yield
- ALDX N/A
- PSF 7.69%
- EPS Growth
- ALDX N/A
- PSF N/A
- EPS
- ALDX N/A
- PSF N/A
- Revenue
- ALDX N/A
- PSF N/A
- Revenue This Year
- ALDX N/A
- PSF N/A
- Revenue Next Year
- ALDX $25.36
- PSF N/A
- P/E Ratio
- ALDX N/A
- PSF N/A
- Revenue Growth
- ALDX N/A
- PSF N/A
- 52 Week Low
- ALDX $1.46
- PSF $16.00
- 52 Week High
- ALDX $6.55
- PSF $20.19
- Technical
- Relative Strength Index (RSI)
- ALDX 54.14
- PSF 35.11
- Support Level
- ALDX $5.28
- PSF $21.11
- Resistance Level
- ALDX $5.37
- PSF $21.39
- Average True Range (ATR)
- ALDX 0.24
- PSF 0.18
- MACD
- ALDX 0.01
- PSF -0.11
- Stochastic Oscillator
- ALDX 77.61
- PSF 5.71
About ALDX Aldeyra Therapeutics Inc.
Aldeyra Therapeutics Inc is a biotechnology company engaged in developing and commercializing next-generation medicines to improve the lives of patients with immune-mediated diseases. The company's product candidate, reproxalap, is a first-in-class treatment in late-stage development for dry eye disease and allergic conjunctivitis. In addition, it also has additional product candidates in development for proliferative vitreoretinopathy, primary vitreoretinal lymphoma and other retinal diseases, autoimmune disease, and cancer.
About PSF Cohen & Steers Select Preferred and Income Fund Inc.
Cohen & Steers Select Preferred and Income Fund Inc is a diversified, closed-end investment company. The Fund's primary investment objective is high current income with capital appreciation as its secondary objective. The Fund invests at least of its Managed Assets in preferred and other income securities issued by U.S. and non-U.S. companies.